ReviR Therapeutics
- Website
- revirtx.com
- Total Funding
- $30.0M
- Last Round
- $30.0M Series AJul 2024
- Rounds
- 1
About
ReviR Therapeutics is a Biotech company. It has raised $30.0M in total across 1 round, most recently a $30.0M Series A round in Jul 2024. Investors include Lapam Capital, CDH Investments and 5Y Capital.
Funding History
Jul 2024
Investors
Similar Companies
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Specialty pharmaceutical company focused on addressing therapeutic needs in the fields of psychia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/revir-therapeutics"><img src="https://indexed.vc/api/badge/company/revir-therapeutics" alt="ReviR Therapeutics on Indexed.vc" width="260" height="76" /></a>